Fungal cultures on cyanoacrylate skin surface strippings as a dose-finding method for topical antifungals. A placebo-controlled study with 0.25% and 0.50% itraconazole cream. 1995

J E Arrese, and P Schrooten, and P de Doncker, and H de Smett, and G Cauwenbergh, and C Piérard-Franchimont, and G E Piérard
Department of Dermatopathology, CHU Sart Tilmon, Liège; Belgium.

The antimycotic activities of 0.25% and 0.50% itraconazole cream were compared in the stratum corneum after once-daily applications for 1 week. Two groups of 12 healthy volunteers applied either itraconazole or placebo on the inner side of each forearm, in a double-blind design. Cyanoacrylate skin surface strippings (CSSS) were taken on days 8, 11 and 21. Conidia or yeasts of selected fungi (Trichophyton rubrum, Trichophyton metagrophytes, Microsporum canis and Candida albicans) were deposited on CSSS. Fungal growth on CSSS was assessed in time by computerized image analysis to derive the inhibitory effect of the previously applied antifungal preparations. Comparable antimycotic activity was found against dermatophytes for both concentrations. Itraconazole 0.50% appeared to be more active than 0.25% against C. albicans. The 0.50% concentration yielded prominent fungitoxic effect after 1 week of treatment, and showed a lingering effect in the stratum corneum for at least 3 days. This method could be useful in a pre-clinical setting and serve as a predictive tool for further clinical dose-finding studies with topical antimycotics.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009172 Mycology The study of the structure, growth, function, genetics, and reproduction of fungi, and MYCOSES.
D011292 Premedication Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. Premedications
D003487 Cyanoacrylates A group of compounds having the general formula CH2 Cyanoacrylate
D003881 Dermatomycoses Superficial infections of the skin or its appendages by any of various fungi. Skin Diseases, Fungal,Dermatomycosis,Dermatophyte Infection,Fungal Skin Diseases
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005658 Fungi A kingdom of eukaryotic, heterotrophic organisms that live parasitically as saprobes, including MUSHROOMS; YEASTS; smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi, commonly known as molds, refer to those that grow as multicellular colonies. Fungi, Filamentous,Molds,Filamentous Fungi,Filamentous Fungus,Fungus,Fungus, Filamentous,Mold
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J E Arrese, and P Schrooten, and P de Doncker, and H de Smett, and G Cauwenbergh, and C Piérard-Franchimont, and G E Piérard
November 1989, Clinical and experimental dermatology,
J E Arrese, and P Schrooten, and P de Doncker, and H de Smett, and G Cauwenbergh, and C Piérard-Franchimont, and G E Piérard
April 1994, Genitourinary medicine,
J E Arrese, and P Schrooten, and P de Doncker, and H de Smett, and G Cauwenbergh, and C Piérard-Franchimont, and G E Piérard
September 1992, Clinical and experimental dermatology,
J E Arrese, and P Schrooten, and P de Doncker, and H de Smett, and G Cauwenbergh, and C Piérard-Franchimont, and G E Piérard
January 1989, Psychopharmacology bulletin,
J E Arrese, and P Schrooten, and P de Doncker, and H de Smett, and G Cauwenbergh, and C Piérard-Franchimont, and G E Piérard
August 1999, The British journal of dermatology,
J E Arrese, and P Schrooten, and P de Doncker, and H de Smett, and G Cauwenbergh, and C Piérard-Franchimont, and G E Piérard
June 2024, Journal of cosmetic dermatology,
J E Arrese, and P Schrooten, and P de Doncker, and H de Smett, and G Cauwenbergh, and C Piérard-Franchimont, and G E Piérard
January 2021, American journal of therapeutics,
J E Arrese, and P Schrooten, and P de Doncker, and H de Smett, and G Cauwenbergh, and C Piérard-Franchimont, and G E Piérard
March 1993, Chest,
J E Arrese, and P Schrooten, and P de Doncker, and H de Smett, and G Cauwenbergh, and C Piérard-Franchimont, and G E Piérard
September 2017, Contemporary clinical trials communications,
J E Arrese, and P Schrooten, and P de Doncker, and H de Smett, and G Cauwenbergh, and C Piérard-Franchimont, and G E Piérard
October 1999, The Journal of rheumatology,
Copied contents to your clipboard!